“i agree that there is risk in both but the lets say the expectation / probability of a commercial success I think lies in the favour of PYC”
”That” is what they’re selling. That’s their angle, their point of differentiation, their “story”.
I mean, who wouldn’t want to have a bunch of de risked pre clinical assets to take through to commercial glory. It has all the hallmarks of a story that’s “to good to be true.”
I’ll believe it when I see it, and would be happy to pay a premium for it. However I believe that I will be offered that chance at a significant discount when the price point reaches its deepest binary risk optionality from maximum doubt by gloomy investors who bought into that “story”.
PYC Price at posting:
10.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)